HMGB1 and plasma cell myeloma: In multiple myeloma, MALAT1 protects HMGB1 from ubiquitin-mediated degradation, elevating HMGB1 levels to drive autophagy and suppress apoptosis, contributing to resistance to chemotherapeutic agents [147].